Truqap (Capivasertib)
Truqap (Capivasertib)
- Medicine Name: Truqap
- API: Capivasertib
- Dosage Form & Strength: Tablets: 160 mg and 200 mg
- Manufactured By: AstraZeneca
Truqap (capivasertib) is a kinase inhibitor used in combination with the drug fulvestrant to treat adult patients who have hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer that is advanced or that has spread/progressed to other parts/organs of the body (metastatic), with an abnormal PIK3CA, AKT1, or PTEN gene, and whose disease has progressed on or after endocrine therapy.
Recommended Dosage: The recommended dosage of Truqap tablets, in combination with fulvestrant, is 400 mg orally twice daily (approximately 12 hours apart) with or without food, for 4 days followed by 3 days off. Continue this therapy until disease progression or unacceptable toxicity. Swallow tablets whole without chewing, crushing, or splitting. Avoid taking tablets that are cracked, broken, or otherwise not intact.
In case a dose is missed within 4 hours of the scheduled time, the patient should take the missed dose. In case a dose is missed more than 4 hours of the scheduled time, the patient can skip the dose and take the next dose at its usual scheduled time.
- Severe hyperglycemia, related to ketoacidosis, occurred in patients treated with Truqap. Evaluate fasting blood glucose (FG) and hemoglobin A1C (HbA1c) and optimize blood glucose before therapy. Evaluate FG at least every two weeks during the first month and at least once a month starting from the second month, before the scheduled dose of Truqap. Monitor HbA1c every three months.
- Severe diarrhea associated with dehydration occurred in patients who received Truqap 160 mg and 200 mg. Monitor patients for signs and symptoms of diarrhea. Advise patients to increase oral fluids and initiate antidiarrheal therapy at the first sign of diarrhea while taking treatment. Withhold, reduce dose, or permanently stop treatment based on severity.
- Cutaneous adverse reactions, which can be critical, including palmar-plantar erythrodysesthesia, erythema multiforme (EM), and drug reaction with eosinophilia and systemic symptoms (DRESS), occurred in those who received Capivasertib. Monitor patients for symptoms of cutaneous side effects. Early consultation with a dermatologist is required. Withhold, reduce dose, or permanently stop treatment on behalf of the severity.
- Capivasertib can be responsible for causing fetal harm when administered to a pregnant woman. Females of reproductive age/potential to use effective contraception during therapy and for one month after the final dose.
What documents are required to import TRUQAP to India?
TRUQAP (capivasertib) tablets can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patients ID proof (issued by the government of India)
How does the order be confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from Doctor
- Import permit if applicable
Is TRUQAP available in India?
TRUQAP (capivasertib tablets) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input
- On availability of Truqap in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
- Medicine Price.
- Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
- Ensuring 100% transparency.
TRUQAP can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Goa, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.
IPN (Indian Pharma Network) can facilitate the supply of TRUQAP (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).
Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Truqap 160 mg/200 mg price in India.
We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.
Indian Pharma Network is able to source the TRUQAP (Cancer Treatment Medicines) from across the globe and has the ability to supply. Indian Pharma offers its customers worldwide access to the best available treatment.
Indian Pharma Network (IPN) is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
What is the Generic Name for the trade name drug Truqap®?
Capivasertib is a Generic Name for the trade name drug Truqap®.
What is the Manufacturer’s Name of Truqap®?
Truqap® is manufactured by AstraZeneca.
Is Truqap® approved by the FDA?
Yes, Truqap® is approved by the FDA. Date of first approval: November 16, 2023.
What is the dosage and form of Truqap® supplied?
Truqap® is supplied as Tablets: 160 mg and 200 mg for oral administration.
What are the most common side effects of Truqap®?
The most common side effects of Truqap® are vomiting, nausea, tiredness, mouth sores, and changes in certain blood tests.
How much does Truqap® cost in India?
The cost of Truqap in India can vary. To procure this kinase inhibitor legally, you can Call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.
What are the storage conditions of Truqap®?
Store the tablets in the original bottle at 20°C to 25°C (68°F to 77°F). Excursions permitted to 15 to 30°C (59 to 86°F).
Is it safe to buy Truqap® online in India?
Yes, one can buy Truqap online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the supply of Truqap® through legal channels.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.